Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials

• Status: Completed
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

We aimed to compare efficacy and safety of combination therapy with oral ofloxacin, 400 mg twice daily, plus oral metronidazole, 500 mg twice daily, for 14 days, with moxifloxacin monotherapy, 400 mg once daily, for 14 days

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Istanbul Bakirkoy Maternity and Children Diseases Hospital
• Treatments: Anti-Bacterial Agents; Antibiotics, Antitubercular; Fluoroquinolones; Levofloxacin; Metronidazole; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination; Ofloxacin

Criteria

Inclusion Criteria:

1. Women diagnosed uncomplicated PID

2. Patients age are between 14 with 45

3. Pelvic tenderness and vaginal discharge

Exclusion Criteria:

1. Urinary Tract Enfections

2. Tubo-ovarian abscess and complicated PID

3. Hıstory of antibiotics treatment

4. Other pelvic pain causes

5. Endometriosis

6. Delivery,abortion and surgery within last months